|
bexmarilimab (3mg/kg) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: FP-1305
Pipeline
Phase 2: 1
Top Sponsors
- Faron Pharmaceuticals Ltd1
Indications
- Higher-risk Myelodysplastic Syndromes1
- Cancer1
Duarte, California1 trial
Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
City of Hope Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.